Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis

REFERENCES

1. 1.↵
   1. National Institute for Health and Care Excellence

   . Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis [Internet. Accessed September 27, 2016.] Available from: www.nice.org.uk/guidance/ta308?unlid=829516852016127114125
2. 2.↵
   1. Vaszar LT,
   2. Orzechowski NM,
   3. Specks U,
   4. Ytterberg SR,
   5. Loftus EV Jr,
   6. Mark EJ,
   7. et al.

   Coexistent pulmonary granulomatosis with polyangiitis (Wegener granulomatosis) and Crohn disease. Am J Surg Pathol 2014;38:354–9.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hinze CH,
   2. Colbert RA

   . B-cell depletion in Wegener’s granulomatosis. Clinic Rev Allerg Immunol 2008;34:372–9.

   OpenUrl
4. 4.↵
   1. Savage CO,
   2. Harper L,
   3. Holland M

   . New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol 2002;14:15–22.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Goetz M,
   2. Atreya R,
   3. Ghalibafian M,
   4. Galle PR,
   5. Neurath MF

   . Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007;13:1365–8.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Lipka S,
   2. Katz S,
   3. Zia R,
   4. Crawford J,
   5. Ramek J

   . Fulminant colitis following rituximab therapy for disseminated B cell marginal lymphoma: P-16. Inflamm Bowel Dis 2012;18:S19–20.

   OpenUrl
7. 7.↵
   1. Blombery P,
   2. Prince HM,
   3. Levinson M,
   4. Pianko S,
   5. Maxwell E,
   6. Bhathal P

   . Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. J Clin Oncol 2011;29:e110–2.

   OpenUrlFREE Full Text
8. 8.↵
   1. Ardelean DS,
   2. Gonska T,
   3. Wires S,
   4. Cutz E,
   5. Griffiths A,
   6. Harvey E,
   7. et al.

   Severe ulcerative colitis after rituximab therapy. Pediatrics 2010;126:e243–6.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. El Fassi D,
   2. Nielsen CH,
   3. Kjeldsen J,
   4. Clemmensen O,
   5. Hegedüs L

   . Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease. Gut 2008;57:714–5.

   OpenUrlFREE Full Text
10. 10.↵
    1. Leiper K,
    2. Martin K,
    3. Ellis A,
    4. Subramanian S,
    5. Watson AJ,
    6. Christmas SE,
    7. et al.

    Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 2011;60:1520–6.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Vallet H,
    2. Houitte R,
    3. Azria A,
    4. Mariette X

    . Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis. J Rheumatol 2011;38:965–6.

    OpenUrlFREE Full Text
12. 12.↵
    1. Borba de Arruda SM,
    2. do Rego Silva AM,
    3. Cezário de Barros KS,
    4. Cunha AM

    . Ulcerative colitis and common variable immunodeficiency: case report. Inflamm Bowel Dis 2009;15:478–81.

    OpenUrlPubMed